MedTrace Logo

Intravenous Vitamin C in the Treatment of Viral Infection, Especially in the Treatment of Shingles

NCT00921934 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2017-12-21

Study results available
· View outcomes & findings →

Summary

Chronic viral infections induce oxidative stress that can cause a number of concomitant diseases, e.g. cardio-vascular diseases or metabolic disorders. Therefore, a sufficient treatment of oxidative stress may be of benefit for the patient to prevent further diseases.

Shingles (herpes zoster infection) have been successfully treated with antioxidative substances like high-dose vitamin C for ages. Not only the acute symptoms can be diminished by high-dose vitamin C. Even long-term sequelae, like painful post-herpetic neuropathy, may be mitigated or even fully avoided.

Conditions

  • Virus Diseases
  • Herpes Zoster

Sponsors & Collaborators

  • Dr. Loges & Co. GmbH

    collaborator INDUSTRY

  • Pascoe Pharmazeutische Praeparate GmbH

    lead INDUSTRY

Principal Investigators

  • Martin Schencking, MD · Rheinstr. 77a, D-56235 Ransbach-Baumbach

  • Bianka Krick · Pascoe Pharmazeutische Praeparate GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921934 on ClinicalTrials.gov